Company news
Allergy Therapeutics plc news in 2017
Allergy Therapeutics plc's news releases, calls and decks from 2017, newest first.
Co-development agreement with Ergomed plc
December 12, 2017
Block Listing Application
November 21, 2017
Allergy Therapeutics to Present at Jefferies 2017
November 13, 2017
Publication of Annual Report and notice of AGM
October 19, 2017
Commencement of dosing in PQ Grass Phase II Trial
October 19, 2017
Hardman Research: Continuing to gain market share
October 10, 2017
Approval for PQ Grass Phase II trial
September 18, 2017
Expansion of Clinical Development and R&D teams
September 11, 2017
Publication of adjuvant studies in journals
July 6, 2017
Investor and analyst site visits
June 27, 2017
Satellite Symposium at EAACI 2017
June 19, 2017
Directorate changes
June 6, 2017
Issue of Equity
April 13, 2017
Hardman Research: Development across portfolio
April 5, 2017
Interim Results for six months ended 31 Dec 2016
March 29, 2017
First Patient in Pivotal Phase III Birch Study
March 16, 2017
Notice of Interim Results
March 9, 2017
House Dust Mite Allergy Vaccine Gains CTA Approval
February 14, 2017
Positive Efficacy & Safety Data in Peanut Vaccine
February 1, 2017
Hardman Research: Investment driving market share
January 20, 2017